ea0093oc10 | Oral communication 2: Neuroendocrinology | EYES2023
Leibnitz Svenja
, Christ-Crain Mirjam
, Winzeler Bettina
Background: Today, GLP-1 receptor agonists have great clinical importance in the treatment of type 2 diabetes and obesity. Furthermore, GLP-1 seems to play a significant role in sodium and water homeostasis. Recent findings investigating long-term effects of treatment with GLP-1 receptor agonists showed a reduction of fluid intake irrespective of food consumption. To our knowledge, data regarding physiological mechanisms that could explain these observations are inconclusive. ...